European Medicines Agency Approves Additional Manufacturing Sites for Pfizer-BioNTech Covid Vaccine

By Giulia Petroni

The European Medicines Agency said Thursday that it has approved two additional manufacturing sites for the production of the Covid-19 vaccine developed by Pfizer Inc. and BioNTech SE.

The sites, which will manufacture the finished product, are set to provide up to 50 million additional doses of Comirnaty by 2021, according to the EU agency.

One site is operated by Sanofi-Aventis Deutschland GmbH, while the other by Siegfried Hameln GmbH. They are both located in Germany.

The European Medicines Agency said the sites can become operational immediately, as the recommendation doesn't require a decision from the European Commission.

Write to Giulia Petroni at [e-mail]

(END) Dow Jones Newswires

09-09-21 1241ET